Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative)

STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)						1 Months Ended	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	Feb. 26, 2021	Sep. 22, 2020	Jun. 15, 2020	Feb. 21, 2020	Dec. 29, 2017	Oct. 31, 2018	Sep. 30, 2021	Sep. 30, 2020	Mar. 31, 2020	Jul. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2018	Mar. 31, 2021	Feb. 09, 2021	Feb. 29, 2020	Jan. 31, 2020	Jul. 17, 2019	Jul. 16, 2019
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount							$ 18,077,000				$ 18,077,000		$ 13,574,000
Debt instrument exercise price		$ 2.00		$ 3.00														$ 5.87
Percentage of monthly payments interest rate				10.00%
Maturity date				Apr. 21, 2021
Conversion debentures price				$ 3.00														$ 9.52
Common stock purchase period		5 years
Share-based compensation											$ 548,000	$ 549,000
Vesting period remaining for recognition of unrecognized compensation expense											1 year 6 months
Addition to equity for common stock									$ 142,000
Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Common stock shares issued for consideration									515,743
Addition to equity for common stock									$ 1,000
2011 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Total unrecognized compensation expense							26,000				$ 26,000
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member]
Class Of Warrant Or Right [Line Items]
Exercisable term											10 years
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member] \| Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Stock options granted to purchase common stock											0		90,000
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member] \| Share Based Compensation Award, Tranche One [Member]
Class Of Warrant Or Right [Line Items]
Vesting period											1 year
Vesting percentage											33.33%
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member] \| Share Based Compensation Award, Tranche Two [Member]
Class Of Warrant Or Right [Line Items]
Vesting period											2 years
Vesting percentage											66.67%
2011 Stock Incentive Option Plan [Member] \| Stock Options [Member]
Class Of Warrant Or Right [Line Items]
Number of shares authorized under the plan														9,000,000
Expiration period											10 years
Vesting period											3 years
Share-based compensation							$ 93,000	$ 121,000			$ 548,000	$ 549,000
Kainos Medicine, Inc [Member]
Class Of Warrant Or Right [Line Items]
Payments to research and development expense	$ 500,000
Common stock shares issued for consideration	324,675
Addition to equity for common stock	$ 500,000
Amended and Restated Warrants [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price															$ 1.54		$ 2.00		$ 5.87
Securities Amendment Agreement [Member]
Class Of Warrant Or Right [Line Items]
Maturity date		Aug. 31, 2021								Apr. 21, 2021
Monthly redemption payment on principal amount		$ 500,000,000								$ 1,000,000,000
Monthly redemptions description											Pursuant to the Allonge, the aggregate monthly redemption payments under the Debentures were reduced to $500,000 from $1,000,000 in principal amount and the maturity date of the Debentures was extended from April 21, 2021 to August 31, 2021. The monthly redemption payments resumed in September 2020 and continued on the first day of each month thereafter commencing October 1, 2020. The remaining principal balance of the Debentures was due and payable upon maturity, subject to mandatory prepayment in connection with certain “Capital Events” as defined.
Convertible Bond Purchase Agreement [Member] \| T.R. Winston & Company, LLC [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price														$ 2.10
Maximum [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock to be purchased		1,840,000
Maximum [Member] \| Convertible Bond Purchase Agreement [Member] \| T.R. Winston & Company, LLC [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock to be purchased														75,000
Amended and Restated Debentures [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price				2.00
Conversion debentures price				$ 2.00
Initial shares under purchase agreement				100,000
Stock price				$ 2.00
10% Secured Senior Debentures [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate							10.00%				10.00%				10.00%
Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Stock price							$ 1.60				$ 1.60		$ 1.68
Number outstanding							1,250,000				1,250,000		1,250,000
Convertible Promissory Note [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount			$ 3,150,000
Debt instrument exercise price			$ 2.05
Percentage of monthly payments interest rate			12.00%										11.00%			2.00%
Conversion price																$ 1.48
Extended maturity date			Jun. 15, 2023
Expected life (in years)			5 years
Number outstanding			1,250,000
Convertible Promissory Note [Member] \| Maximum [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes aggregate purchase price																$ 17,000,000
Senior Secured Convertible Debentures [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate							10.00%				10.00%
Senior Secured Convertible Debentures [Member] \| Amended and Restated Debentures [Member] \| Securities Amendment Agreement [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate		10.00%
GPB Debt Holdings II, LLC [Member] \| Amended and Restated Warrants [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price																				$ 10.00
GPB Debt Holdings II, LLC [Member] \| Maximum [Member] \| Amended and Restated Warrants [Member]
Class Of Warrant Or Right [Line Items]
Debt face amount percentage																				1,460,000
GPB Debt Holdings II, LLC [Member] \| Senior Secured Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Debt face amount percentage					240,764
Debt instrument exercise price					$ 10.80
Initial warrants exercisable period after issuance					5 years
GPB Debt Holdings II, LLC [Member] \| Purchase Agreement With 10% Senior Secured Debentures [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate						10.00%
Principal amount of debentures and warrants issued						$ 12,200,000
Debenture and warrants issued to original loan						$ 13,200,000
GPB Debt Holdings II, LLC [Member] \| Purchase Agreement With 10% Senior Secured Debentures [Member] \| Maximum [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock to be purchased						1,220,000
GPB Debt Holdings II, LLC [Member] \| Amended and Restated Debentures [Member]
Class Of Warrant Or Right [Line Items]
Conversion price																				$ 10.00
GPB Debt Holdings II, LLC [Member] \| Convertible Debt [Member] \| Senior Secured Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount					$ 13,000,000
Convertible notes aggregate purchase price					$ 12,500,000
Original issue discount percentage					4.00%
Debt instrument, repaid date											2018-02